Roberto Galea

Enthusiastic interventional cardiologist with passion for research, traveling and meeting new, interesting people!

[JACC Journals @JACCJournals]

At 13-month #YesCCT evaluation post-LAA closure, the majority of 45-day LAA patency persists, whereas new onset LAA patency is rare. https://t.co/1BjXcsrMK5

#cvLAAoccluder #JACCIMG #cvImaging @vlgmrc

[Davide Capodanno @DFCapodanno]

This newly proposed implanter classification from the European Left Atrial Appendage Closure Club (ELAACC) provides a structured framework to assess anatomical and functional challenges in left atrial appendage closure. https://t.co/kHoKI8Ch06

[Mohamad Alkhouli @adnanalkhouli]

Interested in incorporating routine CCT into your LAAO practice?

Check out the latest expert consensus 📝 on the use of CCT post LAAO published today #JACCINT https://t.co/TM1O2TwDan

[Roberto Galea @RobertoGalea7]

If you want to know more about pericardial effusion LAAC-related read our original research paper just published on Jacc Intv @RaberLorenz @DavidSeiffge @JACCJournals @BernCVRC https://t.co/FXJfN2iG8H

[Reviews in Cardiovascular Medicine @RCMjournal]

📢#RCM-Vol. 24 No. 12

Antithrombotic Therapy after Percutaneous Left Atrial Appendage Closure: Evidence, Challenges and Future Directions

🔓 #OpenAccess
🤵 : @RobertoGalea7 @RaberLorenz ,* of University of Bern @unibern

https://t.co/i1MFNlXJwS

#CardioTwitter #2023review

[Roberto Galea @RobertoGalea7]

If you want to know some tips and tricks about how to approach tricky LAAC cases, don't miss the dedicated session at the EuroPCR Congress! @PCRonline

[Circulation @CircAHA]

#ResearchLetter At one-year, no difference in outcomes was observed between two of the most common left atrial appendage closure devices (Amulet vs Watchman) @RobertoGalea7 @vlgmrc @BernCVRC https://t.co/xUYM0RXLd2

[Anders Kramer @Anders_K_H]

Going home after the very 1st annual @EuropeanLAACC gathering in Barcelona🇪🇸, meeting new friends while promoting a collective European effort towards improving safety and facilitating future quality research in #LAAO!
Bonus quiz: Guess my birdseye view 😎
#ELAACC2024

[Susie Sun @SusieSu11733465]

#RCM #cardiovascular Article Share

💐"Antithrombotic Therapy after Percutaneous Left Atrial Appendage Closure: Evidence, Challenges and Future Directions" by @RobertoGalea7, @RaberLorenz

#LAAC #antithrombotic #bleeding #anticoagulation #AF

💌Full Text:
https://t.co/cFp8ML029f

[PCRonline 🫀 @PCRonline]

#TCT2023 One-year outcomes after Amulet or Watchman/FLX device for percutaneous left atrial appendage closure

@Sticchi_Alex interviews 🎤 @RobertoGalea7 about the 1-year results of the SWISS-APERO randomized clinical trial 📊

https://t.co/k0bUfoOYYL

#cardiotwitter

[Cardiology Today @CardiologyToday]

Catch up on #TCT2023 news you may have missed:

SWISS-APERO at 1 year: LAA closure outcomes similar for Amulet, Watchman devices

@vlgmrc @TCTConference

Link ⬇️

https://t.co/V25Hz388OP

[Roberto Galea @RobertoGalea7]

@dogi84md @natale_md @LuigiDiBiaseMD @EuropaceEiC @DJ_Lakkireddy @docsaw @MoussaMansour10 @BorisSchmidt5 @LukasUrbanek11 @dambrox @michelefg91 @deasnostos @dngibson2 @christophgelle1 @christoffvn Congrats Domenico!

[Roberto Galea @RobertoGalea7]

@Sticchi_Alex @TCTMD Thank you Ale! Really appreciated

[Nicolas Amabile @nicolasamabile]

So glad to finally share !

Computed Tomography Scan Evidence for Left Atrial Appendage Short‐Term Remodeling Following Percutaneous Occlusion: Impact of Device Oversizing | Journal of the American Heart Association https://t.co/n04Ob93ec4

[JACC Journals @JACCJournals]

Drs. @RobertoGalea7, @RaberLorenz et al find significant improvement in procedural success with preprocedural CT to plan LAAC in a post-hoc analysis of the SWISS-APERO Trial. https://t.co/4Pz7NyEKaJ

#JACCINT #cvLAAoccluder #CardioTwitter @chrisgraeni @vlgmrc

[Roberto Galea @RobertoGalea7]

@nicolasamabile Great case Nicolas! The video clearly showed how much resistence you had during the sheath advancement, even after using 2 wires! We had similar cases (stiff wire+IAS dilation), but we never needed a second wire. Congrats and thanks again for sharing the case!

[Roberto Galea @RobertoGalea7]

@RaberLorenz @vlgmrc @chrisgraeni @BernCVRC

[Roberto Galea @RobertoGalea7]

CT-Scan pre-LAAC matters! A subanalysis of Swiss Apero Trial.
.. From @jaccjournals https://t.co/brQePOxC0V

[Roberto Galea @RobertoGalea7]

@adnanalkhouli @RaberLorenz @KPujdak @DocAsger @nicolasamabile I'm glad to read that. The procedure planning seems limited in such a scenario....

[Mohamad Alkhouli @adnanalkhouli]

In a RCT of Apixaban vs Warfarin for dialysis patients with AF published in @CircAHA bleeding events were 10-FOLD more frequent than ischemic events

May be OAC is not the answer here? https://t.co/wQtnZnClUY